# Phase 2: Multimodal Prescription OCR - Discussion Log

- **Topic:** Gray areas for implementation
- **User selected:** "best practices and compliance @agents.md"
- **Resolution:** Deferred to strict compliance with HIPAA, GDPR, and PDPL.
  - Used a mock drug interaction database to avoid sending PHI to un-BAA'd third parties.
  - Enforced a "Review and Confirm" screen for clinical validation before saving.
  - Mandated immutable audit logging for the Edge Function.
